{
    "id": "43c17416-ee88-4973-b5cc-42d903331149",
    "indications": {
        "text": "dexmethylphenidate hydrochloride extended-release capsules indicated treatment attention deficit hyperactivity disorder ( adhd ) [ ( 14 ) ] .",
        "doid_entities": [
            {
                "text": "attention deficit hyperactivity disorder (DOID:1094)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1094"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "patients new methylphenidate : recommended starting dose 5 mg daily pediatric patients 10 mg daily adults without food morning ( 2.2 ) . patients currently methylphenidate : dexmethylphenidate hydrochloride extended-release capsules half ( 1/2 ) current total daily methylphenidate ( 2.2 ) . patients currently focalin tablets : give daily dose dexmethylphenidate hydrochloride extended-release capsules ( 2.2 ) . titrate weekly increments 5 mg pediatric patients 10 mg adult patients ( 2.2 ) . maximum recommended daily dose : 30 mg pediatric patients 40 mg adults ( 2.2 ) . capsules may swallowed whole opened entire contents sprinkled applesauce ( 2.3 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "dexmethylphenidate hydrochloride extended-release capsules available follows : 5 mg : two-piece hard-gelatin capsule aqua-blue-opaque cap aqua-blue-opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5550 \u201d body bottles 100 ( ndc 0093-5550-01 ) . 10 mg : two-piece hard-gelatin capsule ivory-opaque cap ivory-opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5551 \u201d body bottles 100 ( ndc 0093-5551-01 ) . 15 mg : two-piece hard-gelatin capsule blue-green-opaque cap blue-green-opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5552 \u201d body bottles 100 ( ndc 0093-5552-01 ) . 20 mg : two-piece hard-gelatin capsule white-opaque cap white-opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5553 \u201d body bottles 100 ( ndc 0093-5553-01 ) . 25 mg : two-piece hard-gelatin capsule aqua blue opaque cap white opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5045 \u201d body bottles 100 ( ndc 0093-5045-01 ) . 30 mg : two-piece hard-gelatin capsule ivory-opaque cap white-opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5554 \u201d body bottles 100 ( ndc 0093-5554-01 ) . 35 mg : two-piece hard-gelatin capsule aqua blue opaque cap ivory opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5046 \u201d body bottles 100 ( ndc 0093-5046-01 ) . 40 mg : two-piece hard-gelatin capsule blue-green cap white-opaque body , filled white off-white pellets . imprinted black ink \u201c teva \u201d cap \u201c 5562 \u201d body bottles 100 ( ndc 0093-5562-01 ) . store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure ( required ) . keep medications reach children .",
    "adverseReactions": "hypersensitivity methylphenidate components dexmethylphenidate hydrochloride extended-release capsules . hypersensitivity , angioedema anaphylactic reported patients treated methylphenidate [ ( 6.1 ) ] . concomitant treatment monoamine oxidase inhibitors ( maois ) within 14 days following discontinuation treatment maoi , risk hypertensive crises [ ( 7.1 ) ] .",
    "ingredients": [
        {
            "name": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
            "code": "1678OK0E08",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_51860"
        },
        {
            "name": "AMMONIO METHACRYLATE COPOLYMER TYPE B",
            "code": "161H3B14U2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25218"
        },
        {
            "name": "D&C YELLOW NO. 10 ALUMINUM LAKE",
            "code": "CQ3XH3DET6"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "FD&C BLUE NO. 2--ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "HYPROMELLOSE 2208 (3 MPA.S)",
            "code": "9H4L916OBU",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)",
            "code": "74G4R6TH13",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25219"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_168426"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C GREEN NO. 3",
            "code": "3P3ONR6O1S"
        }
    ],
    "organization": "Teva Pharmaceuticals USA, Inc.",
    "name": "Dexmethylphenidate Hydrochloride",
    "effectiveTime": "20250430",
    "indications_original": "Dexmethylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14)].",
    "contraindications_original": "Patients new to methylphenidate: Recommended starting dose is 5 mg once daily for pediatric patients and 10 mg once daily for adults with or without food in the morning ( 2.2 ). Patients currently on methylphenidate: Dexmethylphenidate hydrochloride extended-release capsules dosage is half (1/2) the current total daily dosage of methylphenidate ( 2.2 ). Patients currently on Focalin tablets: Give the same daily dose of dexmethylphenidate hydrochloride extended-release capsules ( 2.2 ). Titrate weekly in increments of 5 mg in pediatric patients and 10 mg in adult patients ( 2.2 ). Maximum recommended daily dose: 30 mg in pediatric patients and 40 mg in adults ( 2.2 ). Capsules may be swallowed whole or opened and the entire contents sprinkled on applesauce ( 2.3 ).",
    "warningsAndPrecautions_original": "Dexmethylphenidate hydrochloride extended-release capsules are available as follows:\n                  5 mg: Two-piece hard-gelatin capsule with aqua-blue-opaque cap and aqua-blue-opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and  \u201c5550\u201d on body in bottles of 100 (NDC 0093-5550-01).\n                  10 mg: Two-piece hard-gelatin capsule with ivory-opaque cap and ivory-opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and \u201c5551\u201d on body in bottles of 100 (NDC 0093-5551-01).\n                  15 mg: Two-piece hard-gelatin capsule with blue-green-opaque cap and blue-green-opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and \u201c5552\u201d on body in bottles of 100 (NDC 0093-5552-01).\n                  20 mg: Two-piece hard-gelatin capsule with white-opaque cap and white-opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and \u201c5553\u201d on body in bottles of 100 (NDC 0093-5553-01).\n                  25 mg: Two-piece hard-gelatin capsule with aqua blue opaque cap and white opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and \u201c5045\u201d on body in bottles of 100 (NDC 0093-5045-01).\n                  30 mg: Two-piece hard-gelatin capsule with ivory-opaque cap and white-opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and \u201c5554\u201d on body in bottles of 100 (NDC 0093-5554-01).\n                  35 mg: Two-piece hard-gelatin capsule with aqua blue opaque cap and ivory opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and \u201c5046\u201d on body in bottles of 100 (NDC 0093-5046-01). \n                  40 mg: Two-piece hard-gelatin capsule with blue-green cap and white-opaque body, filled with white to off-white pellets. Imprinted in black ink with \u201cTEVA\u201d on cap and \u201c5562\u201d on body in bottles of 100 (NDC 0093-5562-01).\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  Keep this and all medications out of the reach of children.",
    "adverseReactions_original": "Hypersensitivity to methylphenidate or other components of dexmethylphenidate hydrochloride extended-release capsules. Hypersensitivity reactions, such as angioedema and anaphylactic reactions have been reported in patients treated with methylphenidate [see Adverse Reactions (6.1)].\n                     Concomitant treatment with monoamine oxidase inhibitors (MAOIs) or within 14 days following discontinuation of treatment with an MAOI, because of the risk of hypertensive crises [see Drug Interactions (7.1)].",
    "drug": [
        {
            "name": "Dexmethylphenidate Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_51860"
        }
    ]
}